PD for Tue 20 Feb 2024 - Scope grows to skin conditions for Vic Pilot, CAPS calls for a gap fee, Aussie men to trial nasal spray for ED, New indication for CSL's Ferinject, and more
Vic pharmacists soon to treat shingles and psoriasis, CAPS urges govt for a gap fee to mitigate 60DD pain, Australian ED trial aims to disrupt oral drug market
Pharmacy Daily - a division of Business Publishing Group PO Box 1010 Epping NSW Australia 1710 Level 2, Suite 1 64 Talavera Rd Macquarie Park NSW 2113 Tel: 1300 799 220 ( 61 2 8007 6760)
To ensure you continue to receive email from Pharmacy Daily reliably please add [email protected] to your 'Safe Senders' list and set images to always display. To forward this email to a friend click here To receive your own copy of Pharmacy Daily sign up here. To modify subscription details click here To unsubscribe click here. You are currently receiving the 'Attachment' version of Pharmacy Daily publications. To switch to a clickable link click here. The Therapeutic Goods (Therapeutic Goods Advertising) Instrument 2021 requires strict compliance. View the code at https://www.legislation.gov.au/Series/F2021L01661.
